NCT01677624

A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Eisai Co., Ltd. · Industry
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the efficacy and safety of transcatheter arterial embolization with E7040 in Japanese subjects with hypervascular tumor or arteriovenous malformation

Conditions

• Hypervascular Tumor and Arteriovenous Malformation

Interventions

Type	Name	Description
DEVICE	E7040	E7040 of optimal particle size (-300 um, 300-500 um, or 500-700 um to fit in a target vessel, target lesion, or embolized area) as transcatheter study device will be administered .

Timeline

• Start date: 2012-08-01
• Primary completion: 2013-12-01
• Completion: 2014-03-01
• First posted: 2012-09-03
• Last updated: 2016-02-22
• Results posted: 2016-02-22

Locations

10 sites across 1 country: Japan